Clinuvel Pharmaceuticals
CUV.AX
#7949
Rank
NZ$0.55 B
Marketcap
NZ$11.01
Share price
0.44%
Change (1 day)
-4.26%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2025: NZ$57.49 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are NZ$62.5 Million. In 2025 the company made an earning of NZ$57.49 Million, an increase over its 2024 earnings that were of NZ$57.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025NZ$57.49 M0.26%
2024NZ$57.34 M11.35%
2023NZ$51.5 M28.31%
2022NZ$40.13 M22.8%
2021NZ$32.68 M112.63%
2020NZ$15.37 M-28.73%
2019NZ$21.57 M32.79%
2018NZ$16.24 M75.41%
2017NZ$9.26 M-332.52%
2016-NZ$3.99 Million-70.68%
2015-NZ$13.59 Million53.78%
2014-NZ$8.84 Million-16.1%
2013-NZ$10.53 Million-37.92%
2012-NZ$16.97 Million-18.19%
2011-NZ$20.74 Million25.31%
2010-NZ$16.55 Million-21.53%
2009-NZ$21.09 Million-11.27%
2008-NZ$23.77 Million80.4%
2007-NZ$13.18 Million-2.46%
2006-NZ$13.51 Million-5.35%
2005-NZ$14.27 Million60.55%
2004-NZ$8.89 Million97.37%
2003-NZ$4.51 Million50.62%
2002-NZ$2.99 Million121.22%
2001-NZ$1.36 Million254.48%
2000-NZ$0.39 Million